Response Biomedical – RAMP 200
The RAMP® 200 by Response Biomedical is a cutting-edge point-of-care device designed to streamline acute care diagnostic testing.
29Nov
29Nov
Response Biomedical – RAMP D-Dimer Test
Abacus dx is pleased to introduce Response Biomedical’s rapid RAMP® D-Dimer test, available on the RAMP 200 POC instrument.
29Nov
Response Biomedical – RAMP Myoglobin Test
Abacus dx is pleased to introduce Response Biomedical’s rapid RAMP® Myoglobin test, available on the RAMP 200 POC instrument.
29Nov
Response Biomedical – RAMP NT-proBNP Test
Abacus dx is pleased to introduce Response Biomedical’s rapid RAMP® NT-proBNP test, available on the RAMP 200 POC instrument.
21Nov
IDS – Bone Turnover Markers
IDS Bone Turnover Markers (BTM) for use with cell culture and animal models.
When addressing changes in bone turnover at the organ or organism level, monitoring tools adequately reflecting the outcome of tissue homeostasis become particularly critical. In this context, bioassays targeting the quantification of various degradation and formation products of bone matrix elements represent a useful approach1.
25Sep
Sebia – Newborn haemoglobin disorders screening
Every day more and more newborns are screened worldwide for metabolic and endocrine disorders. Although screening for haemoglobin has a long history in some countries (USA or UK), in other countries it is a recent addition to their screening panels (Portugal; Germany).
13May
LGC Maine Standards – VALIDATE
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Linearity and calibration verification– confirmation of test stability throughout reportable ranges with VALIDATE® from Maine Standards.
02May
Aidian – QuikRead go CRP
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
C-reactive protein (CRP) is a widely used analyte in healthcare, but do you know why it’s beneficial to measure CRP using point-of-care (POC) testing?
30Apr
Sebia – high-resolution haemoglobin screening method
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Haemoglobinopathies, such as sickle cell disease and alpha/beta thalassemia major, are prevalent genetic disorders that affect the protein part of haemoglobin (Hb).